|
positive regulation of erythrocyte apoptotic process
|
GO_1902252 |
[Any process that activates or increases the frequency, rate or extent of erythrocyte apoptotic process.] |
|
positive regulation of myeloid cell apoptotic process
|
GO_0033034 |
[Any process that activates or increases the frequency, rate, or extent of myeloid cell apoptotic process.] |
|
regulation of signal transduction by p53 class mediator
|
GO_1901796 |
[Any process that modulates the frequency, rate or extent of signal transduction by p53 class mediator.] |
|
positive regulation of bacterial-type flagellum assembly
|
GO_1902210 |
[Any process that activates or increases the frequency, rate or extent of bacterial-type flagellum assembly.] |
|
regulation of prolactin signaling pathway
|
GO_1902211 |
[Any process that modulates the frequency, rate or extent of prolactin signaling pathway.] |
|
negative regulation of prolactin signaling pathway
|
GO_1902212 |
[Any process that stops, prevents or reduces the frequency, rate or extent of prolactin signaling pathway.] |
|
positive regulation of prolactin signaling pathway
|
GO_1902213 |
[Any process that activates or increases the frequency, rate or extent of prolactin signaling pathway.] |
|
regulation of interleukin-4-mediated signaling pathway
|
GO_1902214 |
[Any process that modulates the frequency, rate or extent of interleukin-4-mediated signaling pathway.] |
|
negative regulation of interleukin-4-mediated signaling pathway
|
GO_1902215 |
[Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-4-mediated signaling pathway.] |
|
positive regulation of interleukin-4-mediated signaling pathway
|
GO_1902216 |
[Any process that activates or increases the frequency, rate or extent of interleukin-4-mediated signaling pathway.] |
|
erythrocyte apoptotic process
|
GO_1902217 |
[Any apoptotic process in an erythrocyte.] |
|
myeloid cell apoptotic process
|
GO_0033028 |
[Any apoptotic process in a myeloid cell, a cell of the monocyte, granulocyte, mast cell, megakaryocyte, or erythroid lineage.] |
|
regulation of cellular response to osmotic stress
|
GO_0106049 |
[Any process that modulates the frequency, rate or extent of the cellular response to osmotic stress.] |
|
base-excision repair, AP site formation via deaminated base removal
|
GO_0097510 |
[A base-excision repair, AP site formation process occurring via excision of a deaminated base.] |
|
base-excision repair, AP site formation
|
GO_0006285 |
[The formation of an AP site, a deoxyribose sugar with a missing base, by DNA glycosylase which recognizes an altered base in DNA and catalyzes its hydrolytic removal. This sugar phosphate is the substrate recognized by the AP endonuclease, which cuts the DNA phosphodiester backbone at the 5' side of the altered site to leave a gap which is subsequently repaired.] |
|
dendritic cell dendrite
|
GO_0097511 |
[A branched cellular projection (or cytoplasmic extension) that is extended from the surface of a dendritic immune cell, and which enables the cell to sample luminal pathogens and increase the surface area for antigen presentation to T cells.] |
|
cardiac myofibril
|
GO_0097512 |
[A cardiac myofibril is a myofibril specific to cardiac muscle cells.] |
|
myosin II filament
|
GO_0097513 |
[A bipolar filament composed of myosin II molecules.] |
|
myosin filament
|
GO_0032982 |
[A supramolecular fiber containing myosin heavy chains, plus associated light chains and other proteins, in which the myosin heavy chains are arranged into a filament.] |
|
sexual spore wall
|
GO_0097514 |
[A specialized envelope lying outside the cell membrane of a spore derived from a product of meiosis.] |